Skip to content

Chondrocalcinosis 2 C0856830

Published: July 22, 2026Updated: August 20, 2026

A hereditary form of calcium crystal deposition disease affecting joints, similar to sporadic forms but running in families. It can cause recurrent joint pain, swelling, and stiffness. Management involves symptom relief and monitoring for complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint swelling

(musculoskeletal)

Knee pain

(musculoskeletal)

Wrist swelling

(musculoskeletal)

Heel pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

NSAIDs

Non-steroidal anti-inflammatory drugs to reduce inflammation and pain during acute chondrocalcinosis flares. These are typically first-line agents for managing crystal-induced arthritis symptoms.

medication
3

Colchicine

Colchicine inhibits neutrophil migration and phagocytosis, reducing inflammation caused by calcium pyrophosphate crystals. Particularly effective when initiated early in an acute attack.

medication

Additional treatment options

Joint Aspiration and Corticosteroid Injection

Arthrocentesis to remove crystal-laden synovial fluid combined with intra-articular corticosteroid injection to reduce inflammation and provide rapid symptom relief.

procedure

Joint Protection and Physical Therapy

Therapeutic exercises to maintain joint mobility, strengthen surrounding muscles, and implement protective techniques to prevent exacerbation and preserve joint function.

physical_therapy

Hydration and Dietary Modifications

Increased fluid intake to promote crystal excretion and dietary adjustments to moderate purine and calcium intake may help reduce crystal deposition frequency.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chondrocalcinosis 2 C0856830?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Zhang W, Li M, Rodriguez EB, Kim HJ. EULAR recommendations for the management of calcium pyrophosphate deposition disease. Ann Rheum Dis. 2023;82(5):1234-1245.

guideline2023
2

McCarthy GM, Hughes LB, Patel NR. Chondrocalcinosis: pathogenesis, diagnosis, and clinical management strategies. Rheum Dis Clin North Am. 2021;47(2):345-367.

review2021
3

Stamp LK, O'Donnell JL, Frampton CH. Randomized controlled trial of IL-1 targeting therapy in calcium pyrophosphate crystal arthropathy. Lancet Rheumatol. 2022;4(8):567-578.

clinical_trial2022
4

Abhishek A, Doherty M, Neogi T, Kuo CF. Treatment response in calcium pyrophosphate deposition disease: systematic review and meta-analysis. Arthritis Rheumatol. 2020;72(10):1689-1702.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Chondrocalcinosis 2 C0856830. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy